EDWARDS LIFESCIENCES CORP (EW) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:EW - US28176E1082 - Common Stock
83.92 USD
+0.64 (+0.77%)
84 USD
+0.08 (+0.1%)
ChartMill assigns a Buy % Consensus number of 79% to EW. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 95.83. This target is 14.19% above the current price.
EW was analyzed by 42 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about EW.
In the previous month the buy percentage consensus was at a similar level.
EW was analyzed by 42 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-08 | Barclays | Maintains | Overweight -> Overweight |
| 2025-12-05 | BTIG | Maintains | Buy -> Buy |
| 2025-12-05 | UBS | Maintains | Neutral -> Neutral |
| 2025-12-05 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-12-05 | Stifel | Maintains | Buy -> Buy |
| 2025-12-05 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-12-05 | Truist Securities | Maintains | Hold -> Hold |
| 2025-12-05 | Baird | Maintains | Neutral -> Neutral |
| 2025-12-05 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-11-25 | BTIG | Reiterate | Buy -> Buy |
| 2025-11-03 | Truist Securities | Maintains | Hold -> Hold |
| 2025-11-03 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-10-31 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-10-31 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-10-31 | Stifel | Maintains | Buy -> Buy |
| 2025-10-31 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-31 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-10-31 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-10-31 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-10-31 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2025-10-31 | Citigroup | Maintains | Buy -> Buy |
| 2025-10-29 | Wolfe Research | Upgrade | Underperform -> Peer Perform |
| 2025-10-29 | Jefferies | Upgrade | Hold -> Buy |
| 2025-10-28 | Truist Securities | Maintains | Hold -> Hold |
| 2025-10-08 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2025-10-07 | Evercore ISI Group | Upgrade | In-Line -> Outperform |
| 2025-09-22 | Stifel | Maintains | Buy -> Buy |
| 2025-08-07 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-07-25 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-07-25 | Deutsche Bank | Maintains | Buy -> Buy |
EDWARDS LIFESCIENCES CORP / EW FAQ
Can you provide the average price target for EDWARDS LIFESCIENCES CORP stock?
42 analysts have analysed EW and the average price target is 95.83 USD. This implies a price increase of 14.19% is expected in the next year compared to the current price of 83.92.
What is the consensus rating for EDWARDS LIFESCIENCES CORP (EW) stock?
The consensus rating for EDWARDS LIFESCIENCES CORP (EW) is 79.0476 / 100 . This indicates that analysts generally have a positive outlook on the stock.